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Abstract: Otitis media (OM) is the most common illness in children in the 
United States. Three-fourths of children under the age of three have OM at 
least once. Children with chronic OM, including OM with effusion and 
recurrent OM, will often have conductive hearing loss and communication 
difficulties, and need surgical treatment. Recent clinical studies provide 
evidence that almost all chronic OM cases are accompanied by a bacterial 
biofilm behind the tympanic membrane (eardrum) and within the middle 
ear. Biofilms are  typically very thin, and cannot be recognized using a 
regular otoscope. Here we demonstrate how optical low coherence 
interferometry (LCI) noninvasively depth-ranges into the middle ear to 
detect and quantify biofilm microstructure. A portable diagnostic system 
integrating LCI with a standard video otoscope was constructed and used to 
detect and quantify the presence of biofilms in a newly-developed pre-
clinical animal model for this condition. Using a novel classification 
algorithm for acquired LCI data, the system identified the presence of a 
biofilm with 86% sensitivity and 90% specificity, compared to histological 
findings. This new information on the presence of a biofilm, its structure, 
and its response to antibiotic treatment, will not only provide better 
understanding of fundamental principles that govern biofilm formation, 
growth, and eradication, but may also provide much needed clinical data to 
direct and monitor protocols for the successful management of otitis media. 
©2010 Optical Society of America 
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1. Introduction 
1.1. Otitis media and biofilm 
Otitis media (OM) is a middle ear infection between the tympanic membrane (TM) and the 
inner ear. An ear infection occurs when bacteria grow in the middle ear, causing the 
accumulation of fluid, swelling, and inflammation. Young children often acquire ear 
infections after colds, food allergies, or respiratory infections. Middle ear infections occurs in 
about 75% of children by the age of three, and are the most common cause of visits to a 
physician at this age [1,2]. Classification of ear infections is based on symptoms, duration, 
and physical diagnosis. The most common type is acute otitis media (AOM), which is a rapid 
infection with one or more symptoms such as otalgia, fever, and irritability. In this case, 
physicians often find an abnormal appearing tympanic membrane with pneumatic otoscopy, 
including bulging, opacity, effusion, and decreased mobility. 
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of seven experience at least six recurrent episodes of AOM. Middle ear effusions often follow 
AOM, producing chronic infection. Even though chronic infection can cause long-term or 
permanent damage to the ear, there may be fewer pronounced signs or symptoms of infection 
than in AOM, which may cause the infection to go unnoticed and untreated for an extended 
period of time. Chronic OM can often cause tissue hardening, pus-like drainage, damage to 
the mastoid bone, and damage to the bones in the middle ear involved in hearing [2,3]. 
Therefore, the disease often causes hearing loss and communication impairment, especially in 
small children who are in the process of learning to speak. 
Acute otitis media may clear in one to two weeks without treatment, or may need to be 
treated with antibiotics. About 50% of antibiotic prescriptions for children less than three 
years old are given for ear infections. However, in the case of chronic OM, antibiotics may no 
longer be helpful, and placing a tympanostomy tube in the TM is strongly recommended. The 
tympanostomy tube helps drain the fluid accumulating behind the TM directly into the outer 
ear canal. This surgery is also the most common surgical procedure for young children [2,3]. 
Given the associated morbidity and costs of this disease, it is very important not only to 
accurately diagnose middle ear infections in order to determine the most effective treatment, 
but also to monitor the regression or progression of this disease in a quantitative manner. 
Overuse and misuse of antibiotics in OM haves contributed to resistant bacteria, further 
complicating the management of this disease [4]. The diagnostic challenge is the difficulty in 
discriminating acute OM from chronic OM, and the antibiotic treatment response, using a 
standard otoscope. This challenge exists even for physicians experienced in visually 
investigating the various colors and shapes of the TM, and the presence and characterization 
of any middle ear fluid or effusion. 
Currently, chronic OM  is diagnosed by several methods. Standard otoscopy is most 
frequently used, however the signs of OM are not always apparent. Therefore, the accuracy of 
standard otoscopy is limited with a sensitivity and specificity of 74% and 60%, respectively 
[5]. Other  currently available diagnostic methods such as pneumatic otoscopy and 
tympanometry can yield slightly higher sensitivities and specificities (70-90%) under ideal 
conditions, compared to standard otoscopy [5,6]. However, both pneumatic otoscopy and 
tympanometry still have technical problems with obtaining a good seal within the patient’s ear 
canal, complicating the measurement. Accurate measurements require that the correct size of 
ear speculum be used and depend heavily on patient cooperation. Other factors like cerumen 
or pressure level also have an effect on the measurement accuracy. Therefore, a combination 
of the three methods: otoscopy, pneumatic otoscopy, and tympanometry, if necessary, is now 
recommended for the diagnosis of chronic OM [5,6]. Furthermore, these methods are helpful 
in detecting effusions in chronic OM, but remain limited in their ability to qualitatively or 
quantitatively track changes in the effusion during treatment. 
Recent clinical studies have shown strong evidence that there is a one-to-one 
correspondence between chronic OM and the presence of a bacterial biofilm behind the TM. 
Mucosal biofilms were visualized by confocal laser scanning microscopy in 46 out of 52 
middle ear mucosal specimens from 26 patients undergoing tympanostomy tube placement for 
chronic OM [7]. There are also observations of biofilm formation in induced chronic OM in 
animal models such as the chinchilla and monkey [8]. It has been shown that the pathogenic 
bacteria, Pseudomonas aeruginosa, which exists in all infected middle ear cultures, forms a 
biofilm in the middle ear. 
In general, biofilms are a habitat for complex multi-species micro-organisms (e.g. bacteria, 
fungi, viruses, etc) that grow communally in adhesive self-forming biopolymers. Within 
biofilms, microbes are protected from harsh environments, including antibiotic or biocide 
treatments. Biofilm structures were recently found to be highly heterogeneous in composition 
and architecture including cell distribution, cell aggregation, structural voids, and  fluid 
channels. The presence of a middle-ear biofilm is now considered a reservoir for bacteria and 
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[9–11]. 
1.2. Low coherence interferometry technique 
Low coherence interferometry is an optical ranging technique that is capable of measuring 
one-dimensional depth-resolved tissue structure. To perform LCI, low coherence light is 
generated from a broadband optical source and split by a beam splitter or fiber-optic coupler 
into two beams which are sent to sample and reference arms of the interferometer. The 
reference arm contains a stationary mirror, while the sample arm contains beam-delivery 
optics to direct the beam toward the sample. The interference of the two back-reflected or 
scattered beams is captured by a linear photodetector array and processed by a computer to 
describe the depth-resolved optical scattering properties of the tissue [Fig. 1(a)]. The 
broadband, near-infrared light used in LCI allows for axial resolutions of up to 2-3 µm, and 
penetration depths of up to 2-3 mm in highly-scattering tissues. The spatial variations in the 
optical backscattered signal are used to describe the microstructures of the tissues. With 
additional transverse (lateral) scanning mechanisms and by assembling adjacent depth scans, 
optical coherence tomography (OCT) images can be generated, which represent cross-
sectional images of tissue [12,13]. 
Imaging of the middle ear using the LCI/OCT technique has been demonstrated by several 
research groups [14,15]. With ex vivo OCT imaging, all micro-structures of the middle ear 
such as the TM, malleus, incus, chodra tympani nerve, and tendon of the tensor tympani 
muscle can be readily identified. With high resolution, LCI/OCT is also capable of imaging 
the micro-structure of biofilms, including the dynamics of biofilm formation in a laboratory 
flow-cell experiment where the three-dimensional structure was visualized over time [16]. 
The use of LCI or OCT for middle ear assessment and imaging offers several advantages. 
First, these techniques have the potential to non-invasively detect and quantitatively assess the 
presence of a biofilm behind the TM, while standard otoscopy or ultrasound imaging cannot. 
Second, while both LCI and OCT can provide new useful information, LCI is faster and more 
compact, with fewer requirements for mechanical scanning compared to OCT. Small 
disposable fibers mounted in ear specula can be used to perform LCI, instead of complex 
micro-mechanical scanning systems (MEMs). Even though MEMs-based scanners would 
make OCT imaging of the ear possible [17,18], the LCI technique is more suitable for 
portable systems. Finally, the integration of the LCI system with otoscopy enables a simple, 
low-cost, and non-invasive solution for providing new and quantitative information on the 
middle ear, particularly for detecting, assessing, and monitoring the middle ear for a biofilm, 
and their role in the treatment of OM. 
In previous studies, LCI data have been demonstrated to be efficient for classifying human 
breast tissue [19,20]. Data from the middle ear acquired by an LCI system (i.e., axial scans) 
can be used to quantitatively characterize middle ear structure and classify OM status. In 
general, acute OM and chronic OM can be classified by the absence or presence of a bacterial 
biofilm, respectively. Biofilms and the TM are visualized in LCI data by various scattering 
layers. Here, we present a method to analyze these layers from each axial scan using three 
different parameters: thickness of TM with or without a biofilm layer, intensity of optical 
backscatter, and optical attenuation through structures. The statistical result of axial scan 
classification can be used to determine the likelihood of a biofilm being present, and can 
provide the physician with a quantitative parameter for OM diagnosis. 
For this study, an integrated LCI-otoscope was constructed to acquire middle-ear data 
from a new rat model for chronic middle-ear biofilms. A new classification algorithm for the 
LCI data was also developed to statistically demonstrate, using histological observations as 
the gold standard, the identification of biofilms in the middle ear. 
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2.1. Animal model and biofilm induction 
Demonstration of our LCI system and methodology was first implemented in a new rat OM 
model that we developed explicitly for this research. All animal studies were conducted under 
a protocol approved by the Institutional Animal Care and Use Committee (IACUC) at the 
University of Illinois at Urbana-Champaign.  Streptococcus pneumoniae  biofilms were 
induced in Sprague-Dawley rats (Harlan, Indianapolis, IN) using a minimally-invasive 
technique involving nasal cannula delivery and pressurization to deliver bacteria to the middle 
ear via the Eustachian tube. The rat has previously been widely used as a model for OM, by 
introducing bacteria through a perforated TM or bulla. While there have been many reported 
methods for inducing OM in different animal models [21,22], only one recent report has 
described a protocol for inducing middle-ear biofilms in animals [23]. 
To induce middle-ear biofilms, rats were inoculated biweekly and checked daily for the 
development of OM. Rats were first anesthetized using a subcutaneous injection of Carprofen 
(5mg/kg) followed  by an intraperitoneal injection of ketamine (100mg/kg) and xylazine 
(10mg/kg). A 30 µl volume of Streptococcus pneumoniae  bacteria in a saline/1% 
methylcellulose solution at a concentration of 1 x 10
10 CFU/ml was delivered into the left 
nasal cavity via a  Teflon cannula. The rats were immediately transferred to a pressure 
chamber in which the air pressure was gradually raised to 50 kPa over 5 minutes, held at 50 
kPa for 5 minutes, and then gradually reduced back to atmospheric pressure over 5 minutes. 
In the first group of five animals, four of them were inoculated and one was used as a 
control. The inoculation was initially performed once a week. After 5 weeks without 
observing signs or symptoms of OM, the animal protocol was modified and bacterial 
inoculations were done biweekly instead of weekly. Since biofilms were expected to develop 
after several recurrent OMs, a second animal group of four additional rats was inoculated in 
order to have more animals with OM. 
The increased chamber pressure drove the Pneumococcal  inoculation bolus into the 
middle ear, resulting in acute and chronic middle ear infections and growth of biofilms over a 
total period of 7 months. At various time points, in vivo video otoscopy images and LCI data 
from the TMs of these animals were collected. Normal conditions, acute and chronic 
infections, and middle ear biofilms were observed. All of the TMs were dissected out for 
secondary ex vivo OCT imaging, and were subsequently fixed and embedded in paraffin for 
histological sectioning and comparative examination. 
2.2 Instrumentation 
The integrated otoscopy system was comprised of three main components: the LCI core, the 
LCI probe, and a standard video otoscope. A laptop was used to run custom software to 
control the system and process, analyze, and display both the video otoscope and LCI data. 
This system is compact, portable, and convenient for use in outpatient clinic settings   
[Fig. 1(b)]. 
LCI CORE: A super luminescence diode (SLD) (Pilot-2, Superlum, Ireland) was used as 
the low-coherence light source of the LCI system. This SLD has a center wavelength of 940 
nm and a bandwidth of 70 nm, enabling an axial resolution of ~4.5 µm in tissue. The 
interference fringes generated by back reflections from the sample and reference arms were 
detected by a line-scan camera (P2-22 2K40, Dalsa, Inc.) with 2048 pixels, 10 μm pixel size, 
and 35,000 Hz line rate. The camera was connected to the laptop computer by a PCMCIA 
data acquisition card which supported a camera-link interface (VCE CLCB01, Imperx). 
LCI PROBE: The LCI probe was custom-designed with a small diameter (0.5 - 0.7 mm) and a long working distance 
(12-14 mm) to match the video otoscope optics. A gradient index (GRIN) lens with a diameter of 0.5 mm, length of 
~3.5 mm, and working distance of 6 mm was initially used. The 8° polish angles of the lens prevented large back 
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Fig. 1. Portable LCI otoscope system. (a) Diagram and (b) photograph of the portable system. 
(c,d) Integration of the LCI fiber-based micro-optic probe into the otoscope head. (e) 
Schematic and beam profile of the long working distance LCI probe. 
surfaces of the probe. In order to achieve the long working distance, this lens was then 
polished and glued to the fiber. The polished length of the lens and the glue layer thickness 
were calculated by theory and simulation in a related study [24]. The final probes had a long 
working distance in the range of 12-14 mm and a spot size of ~30 µm (transverse resolution). 
The focused beam profile is shown schematically in Fig. 1(e). 
The distal end of this fiber probe was positioned within a plastic ear speculum tip to 
enable the focused spot to be located within the field of view of the video otoscope image 
[Figs. 1(c) and 1(d)]. A standard video otoscope (Model 23120, Welch Allyn, Inc.) was used 
for these studies so that the real-time otoscope CCD-camera video could be used to track the 
location of the LCI beam, as well as provide digital video imaging of the TM surface 
illuminated with white-light from the otoscope illumination source. This LCI system could 
also readily interface with other standard (non-video) otoscopes as well, provided that an 
additional visible aiming beam was co-linearly propagated with the LCI beam and incident on 
the TM. 
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video images presented in the software user interface enable the guidance of the LCI beam. 
While the 940 nm LCI beam is outside the range for human visual perception, the beam can 
be visualized in the video images by a bright spot, as the silicon-based CCD cameras are 
sensitive out to nearly 1100 nm. The functions of the program such as data acquisition, 
review, storage, and analysis are all designed to be user friendly. 
2.3. Classification algorithm 
Three parameters were extracted from each LCI scan to serve as inputs to the classification 
algorithm. These parameters are thickness of the TM with or without a biofilm layer, intensity 
of optical backscatter, and optical attenuation through the TM and any additional structures 
within the middle ear. The thickness of the TM and biofilm layers is determined by an edge 
detection algorithm [25,26]. The intensity represents the mean signal over the entire depth 
scan and the attenuation is defined by the signal slope. 
First, thickness and intensity of each LCI axial scan were computed. The thickness was 
then analyzed to discard superfluous scans and detect the TM region, because during the data 
collection the probe may be directed to unwanted positions, for example, to the TM region 
over the malleus or to the edges of the ear canal, where the tissue is much thicker and not 
representative of the TM. 
A normal TM is thinner in the central region and thicker around the periphery. Therefore, 
LCI data from the central region of normal TMs were detected and differentiated from other 
data, including data from the periphery of normal TMs and TMs with biofilms or effusion, by 
a hypothesis detection method based on the thickness and intensity parameters. The typical 
thickness of the normal TM is 20 µm for rat and 100 µm for human. Biofilm layers increase 
this thickness by 30-200 µm. 
Signal models, based on the thickness, intensity, and attenuation, were generated from the 
training data and utilized to classify the LCI data. The signal models represented the A-scan 
characteristics of data groups acquired from the central region of normal TMs, periphery of 
normal TMs, TMs with early biofilms, TMs with developed biofilms, and TMs with effusion. 
These groups were formed based on the known structures of TMs [27], biofilms [16], and 
phantoms for effusions. The mean thickness and intensity were first computed by Bayesian 
estimation [25,26]. The training data were then normalized to the expectation value of the 
thickness and intensity. The model was the average of these normalized training data. 
Next, a minimum distance classification was implemented on pre-processed data [25,26]. 
The pre-processing steps normalize the thickness and intensity of the input signal to enable 
pattern matching with the models. The best match model minimized the Euclidean distance 
between the given model and input data (Fig. 2).  
From the result of axial scan classification, data from normal TMs at both the central and 
peripheral regions were considered as normal axial scans. Other data types from TMs with 
biofilms or effusion were considered as abnormal axial scans. Percentages of normal and 
abnormal axial scans from the total acquired axial scans were then used to determine the 
probability of a biofilm with or without an effusion. This quantitative data on the thickness of 
TMs, type and thickness of biofilm, and the presence and type of effusion could also be 
helpful for OM diagnosis. 
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Fig. 2. Signal processing flow-chart for the axial scan classification algorithm. 
3. Results 
During the 7 month animal study, 8 animals were inoculated. One animal that was not 
inoculated served as a control. Noticeable changes were observed in the TMs of the inoculated 
rats compared to the control animal using both the otoscopy images and LCI data, even 
though most inoculated animals did not appear sick during the inoculation period. TMs of all 
inoculated animals were monitored in every inoculation session. Otoscopy images and LCI 
data were captured if any pathological change were found in TMs by standard otoscopy. Ex 
vivo  OCT and histology images of TMs were also acquired if the rat appeared severely 
infected, based on data obtained by otoscopy and LCI. 
The first acute OM was noticed by otoscopy after 7 weeks of inoculations. The TMs of 
this animal had darker and branching vessels, and half of one TM appeared red and cloudy. 
Several acute OMs were also recorded in 3 animals in both groups of rats. However, these 
OMs cleared quickly in 2-3 days. Histological observations from one TM from a rat with 
acute OM confirmed the presence of bacterial colonization behind the TM. The most 
interesting result was found in one animal in the second group. A severe infection was 
observed after 4 months of inoculations, and following two recorded episodes of acute OM. 
The TM from this animal was dark red, prominent, and damaged with two perforations. Data 
from the middle ear of this rat acquired by LCI, OCT, and histology also confirmed the severe 
infection and the presence of additional structures behind the TM. 
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corresponding typical LCI signal showed a single thin structure representing the thin TM   
[Fig. 3(b)]. This thin TM was also confirmed in the corresponding OCT and histology images 
from the same rat [Figs. 3(c) and 3(d)]. The OCT images of the dissected TM were acquired 
with the OCT beam incident on the inner surface of the TM, rather than on the external 
surface, in order to provide a full field-of-view. The narrow external ear canal of the rat 
prohibited OCT imaging across the full width of the TM from this orientation. Major portions 
of the TM were thin, while the periphery of the TM was noticeably thicker. 
 
Fig. 3. Typical in vivo data of normal rat TM acquired with LCI otoscope system. (a) Video 
image of middle ear. (b) LCI axial scan of TM. (c) Validation data from 2-D OCT image 
acquired  ex vivo. (d) Corresponding histology (M, Malleus). The thin membrane is 
representative of the TMs from normal rats. 
In contrast, video otoscopy from the infected TM appeared cloudy, dark red, and with 
prominent perforated regions [Fig. 4(a)]. The LCI signals from the infected rat TM exhibited 
additional scattering structures behind the TM. As an example, in the typical LCI scan, the 
additional structure appeared thick and lower scattering immediately adjacent to the thin and 
higher scattering TM. This structure was ~120 µm thick, six times thicker than the TM from a 
normal rat [Fig. 4(b)]. In the ex vivo OCT images from the middle ear of the infected rat, the 
additional structure behind the TM was confirmed. The presence of the two prominent regions 
with perforations filled by blood was also shown in the OCT images [Fig. 4(c)]. These 
findings from the infected TM were apparent in the histological images as well. Even though 
some portions of the biofilm were not seen in the histological images (likely due to processing 
artifacts) as in the OCT images, the left portion of the biofilm (blue arrows), the two 
perforations (red squares), and bacterial colonies (blues square) [Fig. 4(d)] were evident, 
which validated the presence of a bacterial biofilm as detected in the LCI data. 
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Fig. 4. Typical in vivo data of infected rat TM acquired with LCI otoscope system. (a) Video 
image of middle ear. (b) LCI axial scan of TM. (c) Validation data from 2-D OCT image 
acquired ex vivo. (d) Corresponding histology. Note the increased thickness of the TM and 
biofilm structures in LCI, OCT, and histology images (blue arrows). The prominent areas with 
TM perforations filled by blood, as seen in (a), are also recognized in OCT and histology (red 
squares). 
The in vivo video images of the rat TM are out-of-focus because the very narrow ear 
canals prevented full insertion of the human otoscope ear speculum tip. To enable LCI data 
collection within the small rat ear canal, a bare LCI probe tip was inserted directly, and real-
time LCI signals were used to monitor the position and placement where in vivo LCI data 
were collected, relative to the TM. By this method, 74 in vivo axial scans were successfully 
acquired. Despite this relatively limited number of LCI scans, there was a sufficient number to 
show the presence of additional scattering structures behind the TM, which were indicative of 
a biofilm. 
The classification algorithm was applied to both in vivo and ex vivo LCI data. The ex vivo 
LCI data was extracted from the 2-D OCT images acquired at positions that uniformly 
sampled the full area of the TM, including undesired areas such as areas overlying the 
malleus, and regions at the periphery of the TM. The axial scans from these undesired regions 
over the malleus or peripheral skin regions showed a thickness of ~200-300 µm, compared to 
20-150 µm from the rat TM, with or without a biofilm. Therefore, these scans from undesired 
regions were automatically eliminated by thickness classification. 
Figure 5(a) reports the classification of the LCI data for ex vivo OCT data based on the 
thickness and intensity of the filtered axial scans. There is clear separation between scans 
classified as normal from the control rat (blue circles) and those classified as infected from the 
infected rat (red circles). Some data points from the infected rat (left red circles) fell within 
the normal area because they came from regions of the TM that did not have biofilms, as 
confirmed by histology. Similarly, some data points from normal TMs (right blue circles) fell 
within the area classified as infected. These data points correspond to LCI scans acquired 
from regions over the malleus and around the periphery of the TM, where natural thickening 
occurs. 
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defined categories. From 1,786 axial scans from normal rats, 1,561 scans were classified as 
normal types (blue circles) and 225 axial scans were classified as abnormal types (blue 
crosses). The majority of scans from the normal rats were classified as a normal thin TM. 
From 1,597 axial scans from infected rats, 167 axial scans were classified as normal types (red 
crosses) and 1,430 axial scans were classified as abnormal types (red circles) [Fig. 5(b)]. The 
majority of scans from the infected rats were classified as a TM with an established biofilm. 
The sensitivity and specificity of LCI with this classification algorithm for detecting the 
presence of a biofilm were 87% and 90%, respectively, using histological findings as the gold 
standard. 
Since the in vivo  LCI data were acquired without video guidance, the sensitivity and 
specificity of in vivo  LCI data classification were significantly lower (78% and 83%, 
respectively). Figures 5(c) and 5(d) indicate that a larger portion of data was acquired from 
the peripheral regions of the TMs in the normal rats and from the thin regions of the TM in the 
infected rat. These data increase the false positive and false negative cases and, hence, 
decrease the sensitivity and specificity. 
 
Fig. 5. Acquired and classified axial scan data represented by thickness and intensity. Acquired 
(a) ex vivo OCT data and (c) in vivo LCI data. Classified (b) ex vivo OCT data and (d) in vivo 
LCI data, the cross symbols represent the misclassified axial scans. 
4. Discussion 
Diagnosing chronic OM is a challenge. Normally, chronic OM does not have signs that can be 
easily recognized by otoscopy, as with acute OM. Three popular methods have been used to 
diagnose chronic OM: standard otoscopy, pneumatic otoscopy, and tympanometry. However, 
the accuracy of these methods is limited. Therefore, a combination of these methods is 
currently used for chronic OM diagnosis in order to achieve higher sensitivity and specificity. 
Besides the accuracy of diagnosis, quantitative characterization of acute or chronic OM is also 
limited using the available methods. Thus, a new diagnostic tool for middle ear infections 
which could overcome the discussed limitations is highly motivated. Our work has presented 
a novel diagnostic method for middle ear infections using low-coherence interferometry that 
is able to detect, quantify, and monitor middle ear biofilms non-invasively. A new animal 
biofilm model has also been developed and used for validating our method. 
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collecting LCI and video otoscopy data from this rat middle ear biofilm model. This portable 
system has a depth resolution of ~4.5 µm, an imaging depth range of ~2 mm, and thus is 
appropriate for readily accessing the TM and assessing the presence of biofilms on the inner 
surface, as well as the presence of any middle  ear effusion. The observable differences 
between the LCI signals from normal and infected rat TMs demonstrate the capability and 
sensitivity for detecting middle ear biofilms. These new data offer the possibility to classify 
OM status, to observe and more accurately quantify the association of middle ear biofilm 
growth with the progression of acute OM to chronic OM, and ultimately provide quantitative 
data to direct appropriate therapies. 
Since the rat TM and middle ear structures are similar to those in the human ear (with 
human structures larger in scale), the positive results from this pre-clinical animal study 
demonstrate the potential use of this enhanced otoscopy system for research and clinical use 
for the diagnosis, quantification, and monitoring of human OM. With the current system, axial 
scans are collected continuously in time and randomly in space, guided by both real-time 
video otoscopy and real-time LCI data collection. The collection of a large number of axial 
scans is sufficient to adequately  sample the TM regions and classify the scans. Further 
miniaturization and use of MEMs-based scanners [17,18] would enable the rapid acquisition 
of 2-D and 3-D OCT images, but with increased equipment cost, equipment complexity, and 
longer computational processing and analysis time. 
In addition to the novelty of this enhanced otoscopy system and technique, this study 
represents the first demonstration of biofilm induction and growth by nostral inoculation and 
pressurization in rats. Typically, OM is induced via puncture of the TM, and only recently 
OM has been induced via nostril inoculation. At the time of this study, there had been no such 
animal model for inducing and growing biofilms. Though our rat model had been successfully 
applied for inducing OM and growing biofilms, it was also found to be a challenging model 
for imaging, especially for in vivo OCT, due to the narrow external ear canal. The immune 
system of these rats also proved to be robust against OM. Though OM infections were 
frequently observed for 1-2 days after each inoculation, the infection appeared to be readily 
cleared, despite regular bi-weekly inoculations. Seven of eight inoculated rats did not show 
biofilms despite a long inoculation period and recurrent infections. However, it should be 
noted that this pattern of infection and clearance is not completely unlike the process in 
humans, which is believed to lead to the formation of biofilms over time [7]. As noted, the rat 
outer ear canal is very narrow, prompting the development of long working distance probes, 
and frequently out-of-focus video otoscopy images, resulting in limited video guidance to TM 
locations. Based on these study results, other animal models such as the chinchilla [23] will be 
investigated for future in vivo biofilm growth and antibiotic response studies. 
The noted limitations of out-of-focus video otoscopy and reduced visual guidance of LCI 
beam placement experienced during this animal study are likely to be fully resolved during 
studies in humans. Since the standard otoscope and specula used in this study were designed 
for use in the human ear, which is much larger than the rat ear, the LCI otoscope will have 
both video images and the LCI probe beam in focus. Real-time otoscopy video as well as real-
time LCI data acquisition would be used to guide the LCI probe beam to areas of interest 
across the TM. The real-time guidance would not only lead to the collection of an adequate 
number of axial scans but will also improve the efficiency of the classification by guiding the 
probe to the most pathologically suspicious areas that can be observed by the video. 
The classification algorithm developed during this research has proved to be highly 
effective for classifying LCI data from normal and infected TMs. The results of 86% 
sensitivity and 90% specificity, compared to histological findings, are higher than those for 
the diagnosis of chronic OM (74% and 60%) using standard otoscopy. Other currently 
available diagnostic methods such as pneumatic otoscopy and tympanometry can yield 
slightly higher sensitivities and specificities (70-90%) compared to standard otoscopy, but 
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better sensitivity and specificity for in vivo human LCI data classification, compared to what 
was achieved in this study with rat LCI data classification. In human studies, thousands of 
LCI axial scans will be acquired within 5-10 seconds under video-guidance, which will be 
used for classification. This rapid collection of LCI data is expected to be less dependent on 
patient cooperation than one measurement using pneumatic otoscopy or tympanometry, which 
commonly requires 10-30 seconds. Directing the LCI probe to the areas on the TM which are 
highly suspicious under otoscopy observations should also yield an expected improvement in 
sensitivity and specificity since fewer scans would be collected from regions that would not 
contain biofilms, such as over the malleus or from the epithelial tissue regions around the 
periphery of the TM. Since video otoscopy images are captured simultaneously as the LCI 
depth-scan data, and since the location of the LCI beam on the TM can be visualized on the 
video images, it is possible to use computer image processing methods to automatically 
determine which LCI scans were not from the TM, and discard these data prior to 
classification. The variety of clinical pathologies and additional training data collected over 
time are expected to further enhance the characteristics of the signal models and subsequently 
further improve the sensitivity and specificity of the classification algorithm. 
Otitis media is one of the most common diseases in children. Detecting chronic OM and 
tracking antibiotic responses are the major challenges for the diagnosis and treatment of OM. 
Based on the correspondence between chronic OM and the presence of a bacterial biofilm 
behind the TM, we were able to diagnose chronic OM by detecting bacterial biofilms in the 
middle ear. To summarize, using an enhanced portable otoscopy system we demonstrated the 
application of LCI/OCT for OM diagnosis and the detection, classification, and quantification 
of middle ear biofilms in a new animal model for this disease. LCI signals with high axial 
resolution were selected to classify TMs and additional structures like biofilms and effusions 
related to chronic OM. The real-time data, assessment, and classification captured in an 
office-based clinical setting have the potential for assisting in the management of chronic OM. 
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